Skip to cookie consent Skip to main content

Remy’s Story: Adaptive Radiation Therapy for Ewing Sarcoma

5 minute read
Remy and his dad with care team members from the Mass General Brigham Cancer Institute
Remy and his dad with care team members from the Mass General Brigham Cancer Institute

When 12-year-old Remy Dumas began experiencing persistent hip pain, his parents, Doug and Melinda, assumed it might be a sports injury or growing pains. Remy, an energetic and active pre-teen, had always been healthy, making the sudden discomfort all the more concerning.

It wasn’t obvious from the outside — the tumor never protruded past his skin — but his father noticed subtle changes: Remy was losing weight, becoming fatigued and didn’t seem like himself.

Concerned about sudden changes in Remy’s health, his father pushed for further testing. Imaging confirmed the diagnosis: Ewing sarcoma, a rare bone cancer that primarily affects children and adolescents.

The disease begins in the bones and can sometimes spread to other parts of the body, most commonly the lungs or bone marrow.

The diagnosis marked the start of an intense journey through chemotherapy and radiation — one that would ultimately place Remy at the forefront of a new chapter in cancer care.

Beginning treatment

Following an initial course of chemotherapy, Remy responded exceptionally well. The treatment shrank the tumor and cleared most of the small spots in his lungs.

To address the remaining tumor in his pelvis, the family met with Hesham Elhalawani, MD, MSc, of the Mass General Brigham Cancer Institute. Dr. Elhalawani specifically serves as the director of Pediatric and Young Adult Radiation Oncology at Brigham and Women’s Hospital.

Dr. Elhalawani introduced adaptive radiation treatment (ART), a novel approach not yet widely used in children with cancer and an alternative to a complex surgery that could have required removing part of his pelvic bone and years of rehabilitation.

Exploring adaptive radiation treatment

After much deliberation and research, Doug and Melinda decided to give Remy the best chance with the ART.

He made history as the first pediatric patient at Brigham and Women’s Hospital ever to receive ART using the Ethos system — a technology that personalizes treatment in real-time.

“Traditionally, once a radiation plan is created at the start of therapy, the same plan is used every day,” said Dr. Elhalawani. “But children’s bodies can change quickly during treatment—tumors can shrink, organs can move, and a child’s anatomy can shift as their bladder or bowels fill differently each day. All these changes can affect how accurately radiation hits the tumor or spares developing internal organs, which could inadvertently impact their function in the long term.” 

Remy’s parents recall being initially surprised when told that their son would be the first child in Massachusetts to undergo this type of treatment.

“It was overwhelming at first,” said Doug. “But when Dr. Elhalawani and the team explained how it worked and how carefully they would monitor everything, we felt confident it was the right choice.”

Remy rings the bell after completing ART treatment.
Remy rings the bell after his last ART treatment

Comfort and support during ART

Adaptive treatment sessions typically lasted about 50 minutes, during which Remy was able to communicate with his care team through an intercom system. The experience was made even more comfortable thanks to AVATAR, an audiovisual system that allows patients to watch movies or shows during treatment. These small comforts helped make the highly precise radiation sessions more manageable, keeping him calm and engaged throughout. 

“Remy would be completely immersed in the world of Demon Slayer as if he were watching the show from the comfort of his sofa and not on the treatment table while he received radiation,” said Dr. Elhalawani. “It was so heartwarming to see Remy grasping more glimpses of his normal life while educating us about the show’s characters.”

Remy completed his primary course of radiation just in time for Halloween. Thanks to careful planning and the support of his friends, he was able to join in the festivities, celebrating in costume and enjoying the holiday.

“I was so glad I was able to trick or treat with my friends. It was a great night,” said Remy.

Ongoing care and community support

Although Remy’s primary radiation is complete, he will continue chemotherapy for three more months, followed by low-dose radiation to his lungs to reduce the risk of recurrence. Throughout the journey, the Dumas family has received overwhelming support from friends, neighbors, and medical staff.

“Keeping morale up is one of the most important parts of this journey. Every act of kindness, every gesture of support – it adds to your strength,” said Doug.

As treatment continues, Remy’s story illustrates the potential of modern childhood cancer care: the integration of advanced technology, personalized planning, and human compassion. 

Doug emphasized the importance of asking questions, advocating for your child, and learning as much as possible about treatment options, especially when navigating novel therapies.

“If I had to make the decision again, I’d still choose this path,” Doug said. “The team at Mass General Brigham Cancer Institute was incredible — they gave us confidence every step of the way. I can’t say enough about the level of care, compassion and professionalism we experienced there.”